Organon & Co. (OGN)
|52 Week Range||22.88-39.475|
|1y Target Est||-|
|DCF Unlevered||OGN DCF ->|
|DCF Levered||OGN LDCF ->|
|Debt / Equity||-1079.08%||Strong Sell|
Upgrades & Downgrades
Latest OGN news
Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 16, 2023
6 February 2023
JERSEY CITY, N.J.--( BUSINESS WIRE )--Organon (NYSE: OGN), a global women's healthcare company will release its fourth quarter and full year 2022 financial results on February 16, 2023, prior to the c...
Will Organon (OGN) Beat Estimates Again in Its Next Earnings Report?
27 January 2023
Organon (OGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Organon & Co. (OGN) CEO Kevin Ali Presents at 41st Annual J.P. Morgan Healthcare Conference (Transcr...
10 January 2023
Organon & Co. (NYSE:OGN ) 41st Annual J.P. Morgan Healthcare Conference January 10, 2023 10:30 AM ET Company Participants Kevin Ali - CEO Matt Walsh - CFO Conference Call Participants Chris Schott - J...
12 Stocks Turned $10,000 To $277,126 In 12 Months
30 December 2022
Most S&P 500 investors lost nearly 20% this year. But plenty of moneymaking stocks jumped higher.
Organon To Present at the 41st Annual J.P. Morgan Healthcare Conference
15 December 2022
JERSEY CITY, N.J.--( BUSINESS WIRE )--Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in a firesi...
Organon & Co. (OGN) Presents at Piper Sandler 34th Annual Healthcare Conference
29 November 2022
Organon & Co. (NYSE:OGN ) Piper Sandler 34th Annual Healthcare Conference November 29, 2022 9:00 AM ET Company Participants Kevin Ali - Chief Executive Officer Matt Walsh - Chief Financial Officer Con...
Organon: Q3 Results Show Promising Acquisitions But Mixed Portfolio Sales
24 November 2022
Organon's third-quarter results show third consecutive quarter of growth, with steady growth across divisions. From inception they have undergone a string of acquisitions and licensing deals that may ...
Organon & Co. (OGN) Q3 2022 Earnings Call Transcript
3 November 2022
Organon & Co. (NYSE:OGN ) Q3 2022 Earnings Conference Call November 3, 2022 8:30 AM ET Company Participants Jennifer Halchak – Vice President, Investor Relations Kevin Ali – Chief Executive Officer Ma...
Organon To Report Third Quarter Results and Host Conference Call on November 3, 2022
20 October 2022
JERSEY CITY, N.J.